The South America Respiratory Devices market is expected to reach a market size of more than USD 2.91 Billion by 2031.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • Market Size (2020): USD 2.91 Billion
  • Largest Market: Brazil
  • Fastest Market: Colombia
  • Format: PDF & Excel
Featured Companies
  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • More...

Market Analysis

The market for respiratory equipment in South America has steadily progressed in response to both local health priorities and advancements in respiratory treatment. In the past, obtaining respiratory care in this region was hampered by inconsistent healthcare systems and limited funding. However, an increased awareness of respiratory illnesses as a significant public health issue has transformed the market’s goals and reach. There is a growing emphasis by governments and health organizations on enhancing access to vital respiratory services, particularly for low-income communities and rural areas. Initially, the focus was on using nebulizers, basic oxygen therapy systems, and oxygen concentrators, which became standard in public hospitals for treating asthma, COPD, pneumonia, and acute respiratory infections. During outbreaks of infectious diseases, emergency ventilators gained importance, highlighting their critical role. These respiratory devices are designed to assist or improve lung function by supplying oxygen, aerosolized medication, or ventilatory support, which is crucial for treating both infectious diseases like tuberculosis as well as chronic conditions associated with smoking and air pollution. Recently, advancements in technology have focused on affordability, durability, and ease of maintenance essential factors for public hospitals with limited resources. Regulatory bodies such as Brazil’s ANVISA ensure that products meet safety, performance, and quality standards, enhancing market trust, reducing clinical risks, and encouraging international manufacturers to increase their distribution networks across South America, thus integrating more closely with the respiratory devices market. According to the research report, " South America Respiratory Devices Market Research Report, 2031," published by Actual Market Research, the South America Respiratory Devices market is expected to reach a market size of more than USD 2.91 Billion by 2031. This growth is driven by a rising burden of respiratory diseases, increasing urban development, and gradual enhancements in healthcare investment.

Recent changes show a rise in imports of respiratory devices since many nations depend on manufacturers to fulfill demand, alongside heightened public health funding intended to improve hospital capabilities and readiness for emergencies. Leading companies like Philips and ResMed are present in the market, providing a range of products including oxygen concentrators, ventilators, and devices for sleep apnea and home respiratory care. Their strategies frequently include collaborations with local distributors to address regulatory challenges, pricing issues, and fragmented healthcare systems. Local and regional distributors play an essential role in delivering products, providing training, and offering maintenance services. The South America respiratory devices market is seeing growing opportunities due to continuous improvements in healthcare infrastructure, modernization efforts of public hospitals, and increasing awareness of chronic respiratory diseases. With a focus on enhancing access, resilience, and affordable care, the region offers long-term growth possibilities for manufacturers that provide dependable, cost-effective, and scalable respiratory solutions. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Increasing incidence of chronic and infectious respiratory illnesses: South America is witnessing a rise in cases of asthma, COPD, and respiratory infections. Urban air pollution and smoking play significant roles in this trend. Changes in climate heighten susceptibility to respiratory issues. The growing elderly population elevates the occurrence of chronic diseases. Public health initiatives enhance awareness of respiratory diseases. There is an increasing need for diagnosis and treatment. These points propel market growth.

• Steady advancements in healthcare infrastructure: Governments are making investments to improve healthcare systems. The growth of public hospitals enhances the ability to care for respiratory patients. There is a rise in private healthcare options in city areas. Access to medical technologies is being enhanced. Support for healthcare improvement comes from international aid and collaborations. The training of health professionals is on the rise. Expansion of infrastructure encourages the use of medical devices. Market Challenges

• Limited reimbursement and funding constraints: In various nations, healthcare budgets are restricted. Payments for respiratory devices are often unreliable. Many patients must cover costs themselves. The high price of devices limits access for many. Delays in public purchasing slow down sales processes. Financial issues affect how money is spent on healthcare. These conditions hinder market growth.

• Dependence on imports and supply chain risks: A majority of respiratory equipment is brought in from outside South America. Import taxes make products more expensive. Changes in currency values impact what consumers can afford. Interruptions in the supply chain can postpone the availability of devices. The lack of local production limits growth potential. Navigating regulatory approvals complicates matters. This reliance continues to be a significant issue. Market Trends

• Increased demand for basic and mid-range respiratory devices: There is a high demand for affordable and long-lasting devices. Basic forms of oxygen therapy and nebulizers are prevalent. Hospitals tend to choose dependable mid-range options. Public healthcare prioritizes fundamental respiratory services. Finding a balance between cost and performance is vital. Suppliers are adjusting their product lines to meet this demand. This trend helps maintain market balance.

• Growing adoption of home-based respiratory care:The practice of respiratory therapy at home is slowly growing. Many patients prefer to receive care outside of hospital settings. Portable oxygen concentrators facilitate this transition. Home care lightens the load on the healthcare system. Awareness around managing chronic illnesses is on the rise. The ease of using devices and their portability are highly valued. Home care represents a developing area of growth.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Segmentation

By Product Type Therapeutic Devices
Monitoring Devices
Diagnostic Devices
Consumables and Accessories
By Disease Indication Chronic Obstructive Pulmonary disease (COPD)
Sleep Apnea
Asthma
Infectious Diseases
Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)
By End User Hospitals
Ambulatory Care Centers (ACCs)
Home care Settings
Other End User
South America North America
Europe
Asia-Pacific
South America
MEA



Monitoring devices are expanding rapidly due to the growing focus on early detection, disease monitoring, and budget-friendly management within limited-resource healthcare systems.

The segment of respiratory devices focused on monitoring is the most rapidly expanding category in the South American market for these healthcare items as medical systems move toward finding illnesses earlier and managing them preventively. In the past, a lack of diagnostic capabilities caused patients with respiratory issues like COPD, asthma, and lung problems following infections to seek care at later stages. Now, both governments and health organizations are emphasizing affordable monitoring solutions like pulse oximeters, spirometers, and portable respiratory monitors to enhance early detection and ongoing disease management. These tools are generally inexpensive, straightforward to implement, and can be used effectively in primary care settings, rural health facilities, and home environments, making them appealing in areas with limited resources. The accelerated use of pulse oximetry in South America, solidifying the role of monitoring devices in everyday care routines. Furthermore, the increasing awareness regarding the management of chronic respiratory diseases has driven up the need for frequent assessments of lung function and oxygen levels. Monitoring tools can lessen the number of hospital admissions by allowing health professionals to take action sooner, which aligns with the financial management goals of public health systems. Greater imports, healthcare programs supported by donations, and public purchasing initiatives have improved accessibility to these instruments. Incorporating digital features, such as basic data links and remote reporting, boosts their usefulness. As South America continues to enhance its primary care and community health systems, monitoring tools are witnessing the highest growth among the various types of respiratory devices.

Sleep apnea is rapidly increasing due to higher obesity rates, better diagnosis, and a growing acceptance of home sleep therapy devices.

Sleep apnea is now the fastest-growing disease indication in the South America respiratory devices market as awareness and diagnosis continue to advance throughout the region. Previously underdiagnosed, sleep apnea is now more commonly understood due to its significant associations with cardiovascular disease, hypertension, diabetes, and decreased productivity. South America has seen a rise in obesity and less active lifestyles, mainly in urban communities, leading to a larger at-risk population. Healthcare professionals are increasing the screening for sleep disorders through pulmonology clinics and primary care providers, resulting in climbing diagnosis figures. Continuous Positive Airway Pressure CPAP and BiPAP machines are becoming more widely available thanks to enhanced imports, partnerships for regional distribution, and a growing acceptance of home treatment options. Both public and private healthcare sectors are slowly endorsing long-term sleep therapy to minimize future healthcare expenses related to untreated sleep apnea. Advancements in technology, such as quieter, smaller, and more user-friendly devices, have improved adherence from patients. The shift towards homecare solutions is particularly crucial in South America, where hospital resources are constrained and cost-effectiveness is paramount. Moreover, the increased emphasis on respiratory health following the pandemic has prompted earlier interventions. As costs become more manageable and clinical awareness rises, sleep apnea is distinguishing itself as the fastest-growing disease category in South America's market for respiratory devices.

Home care environments are the fastest-growing end user in the South America respiratory devices market due to cost-effectiveness, increasing chronic respiratory illnesses, and the rising availability of portable home respiratory solutions.

The By End User Home Care Settings segment is the fastest-growing in the South America respiratory devices market as healthcare systems across the area progressively transition to more decentralized and cost-efficient care methods. South America encounters a heightened occurrence of chronic respiratory conditions like COPD and asthma, which require ongoing management instead of continual hospital stays. Home care presents a more economical option for both patients and healthcare providers, especially in nations with limited healthcare funding. Developments in portable oxygen concentrators, nebulizers, and CPAP machines have made respiratory therapy at home more practical and attainable. Patients also favor home treatments because of enhanced comfort, less travel hassle, and decreased out-of-pocket costs. Governments and healthcare organizations are encouraging home care to alleviate hospital congestion and optimize resource use. Increasing awareness about managing chronic diseases and the gradual growth of home healthcare services further promote adoption. These aspects together establish home care settings as the segment growing the fastest among end users in the South America respiratory devices market.

Market Regional Insights


Brazil stands at the forefront of the respiratory devices market because of strong local demand stemming from chronic respiratory illnesses, government healthcare programs, and an expanding medical device sector.

Brazil's prominent position in the respiratory devices market is due to a blend of significant local needs, active government healthcare strategies, and a burgeoning industry for medical equipment. The high prevalence of chronic respiratory conditions, such as asthma and chronic obstructive pulmonary disease, has led to an increased necessity for respiratory support devices. The Brazilian government has implemented various initiatives to improve healthcare infrastructure, encouraging the development and distribution of medical technologies. This governmental backing has played a crucial role in making respiratory devices more affordable and accessible to the population. Furthermore, there has been a notable growth in Brazil's medical device industry, which has fostered local production capabilities and attracted investments in innovation. The country has also expanded partnerships between healthcare institutions and manufacturers, enhancing the integration of modern technologies and practices. The rising awareness of respiratory health among the Brazilian populace, influenced by urbanization and environmental factors, has contributed to a surge in demand for devices like nebulizers and oxygen concentrators. The importance of respiratory equipment and further escalated the domestic market's growth as manufacturers quickly adapted to meet the increased demand. The combination of these factors, including efforts to strengthen research and development, as well as collaborations with international companies, has enabled Brazil to solidify its role in the respiratory devices sector. Consequently, Brazil not only serves as a significant manufacturer of these essential devices but also as an innovator within the industry, responding effectively to the changing healthcare landscape.

Companies Mentioned

  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • 7 . Stryker corporation
  • 8 . Siemens AG
  • 9 . GE Healthcare
  • 10 . Vapotherm Inc.
  • 11 . Fisher & Paykel Healthcare Corporation Limited
  • 12 . Dragerwerk AG & Co. KGaA
  • 13 . Juki Corporation
  • 14 . Nidek Medical Products Inc.
  • 15 . Besco Medical Limited

Table of Contents

  • Table 1: Influencing Factors for Respiratory Devices Market, 2025
  • Table 2: Top 10 Counties Economic Snapshot 2024
  • Table 3: Economic Snapshot of Other Prominent Countries 2022
  • Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 5: South America Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 6: South America Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 7: South America Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 8: Brazil Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 9: Brazil Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 10: Argentina Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 11: Argentina Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 12: Colombia Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 13: Colombia Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 14: Competitive Dashboard of top 5 players, 2025

  • Figure 1: South America Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 2: South America Respiratory Devices Market Share By Country (2025)
  • Figure 3: Brazil Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 4: Argentina Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 5: Colombia Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 6: Porter's Five Forces of Global Respiratory Devices Market

Market Research FAQs

Commonly used respiratory care devices in South America include ventilators, oxygen concentrators, continuous positive airway pressure (CPAP) devices, nebulizers, spirometers, and portable oxygen tanks, among others.
Key factors driving market growth include the high prevalence of respiratory diseases, improvements in healthcare infrastructure, increasing awareness of respiratory health, technological advancements, and government initiatives to improve healthcare access and quality.
The COVID-19 pandemic has led to an increased demand for respiratory care devices such as ventilators and oxygen concentrators. It has also accelerated the adoption of telemedicine and remote monitoring solutions in the region.
Countries with larger healthcare infrastructures and populations, such as Brazil and Argentina, typically have a significant market share for respiratory care devices.
Emerging trends in the market include the adoption of telehealth and remote monitoring, the development of portable and user-friendly devices, and a focus on sustainability and environmental considerations.
The rising demand is being driven by a higher rate of respiratory diseases, increasing pollution, more hospital admissions for respiratory conditions, and government healthcare initiatives.
Inhalers, nebulizers, and ventilators are frequently employed, with inhalers being favored for domestic use and ventilators being more prevalent in hospitals for patients in critical condition.
Major challenges comprise inconsistent healthcare systems, high prices for devices, limited knowledge regarding proper use, and issues with regulations and reimbursements.
Brazil, Argentina, and Chile are leading markets due to health initiatives from the government, increased use of advanced devices, and heightened patient awareness.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags